Progress and Potential for Achieving Cleaner Air on a Global Basis
Adoption of New Generation Diesel Technology Delivers Rapid Clean Air Benefits
New understanding of global air quality highlights the need for technologies like new-generation diesel engines, which are capable of accelerating emissions reductions
WASHINGTON, April 19, 2018 (GLOBE NEWSWIRE) -- Recent reports highlighting air quality conditions in the United States (State of the Air) and globally (State of Global Air 2018) celebrate the progress made in developed and developing countries, but also emphasize significant disparities in progress toward reducing levels of key pollutants such as particulate matter and ozone.
"Achieving continued clean air progress while also sustaining economic growth is possible. Cities and countries must move to proven cleaner engines and fuels," said Allen Schaeffer, executive director of the Diesel Technology Forum. "We can and should bring the tremendous benefits of new technology diesel engines to communities and countries large and small around the world so they too can reduce emissions while efficiently building their economies and infrastructure, improving the quality of life for people everywhere."
"While it is surprising the extent that particulate matter from household cooking and non-transportation sources contributes to the health burden in the new report, the opportunities for reducing fine particle emissions from the motor vehicle and industrial engine segments are also part of the solution," said Schaeffer. "Worldwide harmonization of fuel quality and vehicle engine emissions standards would leverage the societal benefits of new diesel technology to more users around the world."
For example: Today, nearly one in every two trucks on the road in the United States are equipped with fine particle- and smog-reducing advanced clean diesel technology. In the most comprehensive study conducted on these engines, The Health Effects Institute found "substantial emissions and health benefits from US 2007/2010 and Euro VI/6 engines," demonstrating "dramatic improvements in emissions and the absence of any significant health effects."
In 2000, the U.S. Environmental Protection Agency (EPA) challenged diesel engine and truck manufacturers to achieve near-zero emissions in their products by 2010, with diesel off-road equipment manufacturers targeting 2014. Following a switch to ultra-low-sulfur diesel fuel in 2006, today's industry has not only met the near-zero challenge, but is well into the second and third generations of new diesel technologies. The industry continues to build on this success by seeking lower greenhouse gas emissions and greater fuel efficiency for the diesel engine.
The societal benefits of these efforts are now clear: According to the American Lung Association's analysis, ".the best progress [in 2018] came in the continued reduction of year-round particle pollution, thanks to cleaner power plants and increased use of cleaner vehicles and engines."
"Clean diesel technology plays an increasing role in helping cities, states and countries achieve cleaner air quality worldwide," said Schaeffer. "The latest generation diesel engines - ones that use selective catalytic reduction systems and diesel particulate filters - offer near-zero particulate matter (PM) and nitrogen oxides (NOx) emissions. With such technology, NOx emissions can be reduced by up to 90 percent while simultaneously reducing hydrocarbon and carbon monoxide emissions by 50-90 percent, and PM emissions by 30-50 percent. Ultra-low-sulfur diesel fuel immediately cuts soot emissions from diesel vehicles and equipment by 10 percent."
The State of Global Air 2018, compiled by The Health Effects Institute, the Institute for Health Metrics and Evaluation at the University of Washington, and the University of British Columbia, dramatically expands our understanding of all the sources that contribute to fine-particle air pollution; this was identified as the greatest environmental risk factor worldwide. Ninety-five percent of the world's population lives in areas exceeding the World Health Organization's (WHO) guideline for healthy air, and nearly 60 percent live in areas that do not meet even the WHO's least-stringent air quality target.
"Global considerations of air quality improvement must go beyond the road transport sector because diesel engines not only power the majority of commercial vehicles, but also nearly all marine and rail, industrial, agricultural and construction machines and equipment," said Schaeffer. "Similar clean diesel technologies that reduce fine particle emissions from commercial vehicles are now available in these large engine applications."
About The Diesel Technology Forum
The Diesel Technology Forum is a non-profit organization dedicated to raising awareness about the importance of diesel engines, fuel and technology. Forum members are leaders in clean diesel technology and represent the three key elements of the modern clean-diesel system: advanced engines, vehicles and equipment, cleaner diesel fuel and emissions-control systems. For more information, visit http://www.dieselforum.org .
Connect with the Diesel Technology Forum
For the latest insights and information from the leaders in clean diesel technology, join us on Facebook, follow us on Twitter @DieselTechForum, or YouTube @DieselTechForum and connect with us on LinkedIn. Get it all by subscribing to our newsletter Diesel Direct for a weekly wrap-up of clean diesel news, policy analysis and more direct to your inbox.
301.668.7230 (o) 301.706.8276 (c)
The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: Diesel Technology Forum via Globenewswire
Om Nasdaq GlobeNewswire
One Liberty Plaza - 165 Broadway
NY 10006 New York
+1 212 401 8700http://www.nasdaqomx.com
NASDAQ (NASDAQ: NDAQ) is a leading provider of trading, exchange technology, information and public company services across six continents.
Følg saker fra Nasdaq GlobeNewswire
Registrer deg med din epostadresse under for å få de nyeste sakene fra Nasdaq GlobeNewswire på epost fortløpende. Du kan melde deg av når som helst.
Siste saker fra Nasdaq GlobeNewswire
Manufacturing Leadership Forum Will Highlight Enabling Industry 4.0 with Analytics25.9.2018 15:06 | Pressemelding
Upcoming Dates in Houston, Texas and Antwerp, Belgium PORTLAND, Ore., Sept. 25, 2018 (GLOBE NEWSWIRE) -- New dates for The Manufacturing Leadership Forum were announced today including Houston, Texas, US on October 9, 2018 at the Petroleum Club of Houston and on November 28, 2018 in Antwerp, Belgium at the Lindner WTC Hotel & City Lounge. The events are sponsored by Northwest Analytics, a leading provider of manufacturing intelligence and SPC software solutions for manufacturers. This premier manufacturing analytics educational event focuses on enabling Industry 4.0 programs with manufacturing analytics. The Forums will feature keynotes and case-study presentations from globally-recognized leaders in the application of manufacturing analytics. In its fourth year, The Manufacturing Leadership Forum will open with a keynote from analytics visionary, Dr. Lloyd Colegrove, Director of Data Services & Fundamental Problem Solving at The Dow Chemical Company. “The Manufacturing Leadership Foru
Checkpoint Therapeutics Announces Presentation of Updated Data from Phase 1/2 Trial of EGFR Inhibitor CK-10125.9.2018 14:00 | Pressemelding
Data were featured in an oral presentation at the IASLC 19th World Conference on Lung Cancer Phase 3 trial in treatment-naïve EGFR mutation-positive NSCLC patients targeted to commence in 2019 NEW YORK, Sept. 25, 2018 (GLOBE NEWSWIRE) -- Checkpoint Therapeutics, Inc. (“Checkpoint”) (NASDAQ: CKPT), a clinical-stage immuno-oncology biopharmaceutical company focused on the acquisition, development and commercialization of novel treatments for patients with solid tumor cancers, today announced that positive preliminary safety and efficacy data from an ongoing Phase 1/2 clinical trial of CK-101 were presented yesterday in an oral presentation at the International Association for the Study of Lung Cancer (IASLC) 19th World Conference on Lung Cancer in Toronto. The oral presentation included further details on, and updates from, the dataset announced previously. CK-101 is a third-generation epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor (TKI) being evaluated in advanced non
SpeeDx Begins Multisite U.S. Clinical Trials of ResistancePlus® MG Test25.9.2018 14:00 | Pressemelding
Test supports international guidelines for treating antibiotic resistant STI SYDNEY, Australia, Sept. 25, 2018 (GLOBE NEWSWIRE) -- SpeeDx Pty. Ltd. today announced the start of patient testing in their multisite U.S.-based clinical trials for ResistancePlus® MG (not available for sale in the U.S.). The molecular diagnostic test detects the sexually transmitted infection (STI) Mycoplasma genitalium, also known as Mgen or MG, along with genetic markers linked to antibiotic resistance. In recent years, Mgen prevalence has increased globally and developed high rates of resistance to the common antibiotic treatment, azithromycin. "This test is an exciting new development that will increase the precision of patient care for patients impacted by Mycoplasma genitalium - a common sexually transmitted infection with limited treatment options,” notes Dr Maria Trent, Professor of Pediatrics and Public Health at Johns Hopkins Medicine. The SpeeDx ResistancePlus MG test is in use in laboratories acr
Novavax Initiates Phase 2 Clinical Trial of NanoFlu™ in Older Adults25.9.2018 13:00 | Pressemelding
First participants enrolled in Phase 2 clinical trial of quadrivalent NanoFlu formulations Top-line immunogenicity and safety data expected in the first quarter of 2019 Phase 2 results will support meeting with the U.S. Food and Drug Administration (FDA) and Phase 3 clinical trial design GAITHERSBURG, Md., Sept. 25, 2018 (GLOBE NEWSWIRE) -- Novavax, Inc. (NASDAQ: NVAX) today announced the initiation of a Phase 2 dose and formulation confirmation clinical trial in older adults of NanoFlu, its nanoparticle seasonal influenza vaccine candidate. “Initiating this Phase 2 clinical trial of NanoFlu is an important milestone for Novavax,” said Stanley C. Erck, President and Chief Executive Officer of Novavax. “With top-line results expected in the first quarter of 2019, we plan to discuss these data with the FDA at an ‘End of Phase 2’ meeting and to agree on the appropriate Phase 3 clinical trial design to support licensure via accelerated approval. We continue to believe NanoFlu is a differen
CGAP Launches Photo and Video Contest Theme for 2018: Financial Inclusion in Africa25.9.2018 13:00 | Pressemelding
This year's CGAP contest is the first ever to accept short video entries WASHINGTON, Sept. 25, 2018 (GLOBE NEWSWIRE) -- The Consultative Group to Assist the Poor’s (CGAP) 13th annual photo contest, launched today, is seeking striking images on financial inclusion in Africa. For the first time, short video submissions on Africa also will be accepted. Entries may be submitted through December 14, 2018. Each contestant may submit up to 20 photos or videos to compete for the Grand Prize worth US$ 2,000. This year CGAP is looking for original and compelling photographs and short videos that tell the story of how financial services empower poor people and communities in Africa. The region is a center for financial innovation -- home to M-Pesa, the mobile money service launched a decade ago now replicated across markets worldwide; host to vibrant FinTech and e-commerce companies; and to a growing off-grid sector that leverages digital finance. Together these innovators contribute toward lifti
Kick-starting health in the workplace25.9.2018 10:00 | Pressemelding
Over 800 organizations step, bike, swim and yoga their way to better health and wellbeing as the May 2018 Virgin Pulse Global Challenge Concludes ZURICH, Switzerland, Sept. 25, 2018 (GLOBE NEWSWIRE) -- On August 30th more than 270,000 people, across 144 countries, completed Virgin Pulse’s 100-day Global Challenge, moving them towards a more active, healthy and productive lifestyle. With this achievement, Virgin Pulse, an international leader in employee health and wellbeing, once again proves it’s helping to improve employee lives for good. The company’s Global Challenge event encourages exercise, mindfulness and healthy habits at work, leading to a happier culture and reduced costs to the organization. “Through increased awareness, education and motivation, employees master long-term, sustainable habits allowing them to arrive at work feeling more engaged, productive and equipped for peak performance,” says David Osborne, Chief Executive Officer of Virgin Pulse. “The follow-on effects
I vårt presserom finner du alle våre siste saker, kontaktpersoner, bilder, dokumenter og annen relevant informasjon om oss.Besøk vårt presserom